HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xurui Cheng Selected Research

Pathologic Processes

11/2022Therapeutic potential for targeting Annexin A1 in fibrotic diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xurui Cheng Research Topics

Disease

2Neoplasms (Cancer)
11/2021 - 01/2020
1Fibrosis (Cirrhosis)
11/2022
1Pathologic Processes
11/2022
1Nausea
11/2021
1Colorectal Neoplasms (Colorectal Cancer)
11/2021
1Vomiting
11/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2020
1Necrosis
01/2020
1Bradycardia
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Stomach Neoplasms (Stomach Cancer)
12/2013

Drug/Important Bio-Agent (IBA)

2SR 140333IBA
11/2021 - 01/2020
2Aprepitant (Emend)FDA Link
11/2021 - 01/2020
1Annexin A1IBA
11/2022
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
11/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2020
1AnthracyclinesIBA
01/2020
1CalciumIBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2013

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2021 - 01/2020
1Therapeutics
11/2022